Drug Name: | Baclofen (1134-47-0) |
---|---|
PubChem ID: | 2284 |
SMILES: | C1=CC(=CC=C1C(CC(=O)O)CN)Cl |
InchiKey: | KPYSYYIEGFHWSV-UHFFFAOYSA-N |
Therapeutic Category: | Central Nervous System Agents, GABA Agents, GABA Agonists, GABA-B Receptor Agonists, Muscle Relaxants, Neuromuscular Agents, Neurotransmitter Agents, Peripheral Nervous System Agents |
Molecular Weight (dalton) | : | 213.664 |
LogP | : | 1.857 |
Ring Count | : | 1 |
Hydrogen Bond Acceptor Count | : | 2 |
Hydrogen Bond Donor Count | : | 2 |
Total Polar Surface Area | : | 63.32 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|---|---|---|---|
Levodopa (59-92-7) | Confusion | Antagonistic | Not understood | Baclofen in Parkinson's disease |
Levodopa (59-92-7) | Hallucinations! | Antagonistic | Not understood | Baclofen in Parkinson's disease |
Levodopa (59-92-7) | Headache | Antagonistic | Not understood | Baclofen in Parkinson's disease |
Levodopa (59-92-7) | Nausea | Antagonistic | Not understood | Baclofen in Parkinson's disease |
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|---|---|---|
Threshold Normalization | Adenosine A1 receptor (P30542) | In SCS responding rats@ combination of a selective GABA(B) and an adenosine A1 receptor antaGOnist (CGP 55845@ CPT) in low@ ineffective doses abolished the SCS-induced threshold normalization [ ADR Type 1 ] | Effect of spinal cord stimulation on tactile hypersensitivity in mononeuropathic rats is potentiated by simultaneous GABA(B) and adenosine receptor activation |
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category